Article Text
Statistics from Altmetric.com
J F Mann
Dr J F Mann, Munich General Hospitals, Ludwig Maximilians University Munchen, Germany; johannes.mann@kms.mhn.de
STUDY DESIGN
Design:
randomised controlled trial (Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial [ONTARGET]). ClinicalTrials.gov NCT00153101.
Allocation:
concealed.*
Blinding:
blinded (patients, clinicians, and {outcome assessors}†).*
STUDY QUESTION
Setting:
{733 centres in 40 countries.}†
Patients:
25 620 patients ⩾55 years of age who had established atherosclerotic vascular disease or diabetes with end-organ damage. At baseline, mean serum creatinine concentration was 94 μmol/l, mean estimated glomerular filtration rate (eGFR) was 74 ml/min/1.73 m2, and mean urine albumin-to-creatinine ratio (UACR) was 0.82 mg/mmol. Exclusion criteria included major renal artery stenosis, uncorrected volume or sodium depletion, serum creatinine concentration >265 μmol/l, and uncontrolled hypertension. …
Footnotes
Source of funding: Boehringer Ingelheim.